Recombinant Anti-EGFR MAb scFv (MOM-H35-S(P))
|Recombinant Anti-Human EGFR Antibody scFv Fragment
- Product Overview
- Recombinant Chimeric (human/mouse) Antibody scFv Fragment is bind to Human EGFR, expressed in E. coli
- Suitable for use in ELISA, WB, Neut and most other immunological methods.
- Specific Activity
- EGFR (epidermal growth factor receptor, receptor tyrosine-protein kinase erbB-1, ERBB1, HER1, HER-1, ERBB) [Homo sapiens]
- Cellular Localization
- >95.0% as determined by analysis by SDS-PAGE.
- Purified by Nickel ion affinity chromatography
- At -20°C for one year.
- Antigen Description
- The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands
- ATP binding; MAPK/ERK kinase kinase activity; actin filament binding; double-stranded DNA binding; enzyme binding; epidermal growth factor-activated receptor activity; epidermal growth factor-activated receptor activity; identical protein binding; contrib
- EGFR; epidermal growth factor receptor; epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog) , ERBB; ERBB1; erythroblastic leukemia viral (v erb b) oncogene homolog (avian); proto-oncogene c-ErbB-1; cell growth inhibiting protein 40; cell proliferation-inducing protein 61; receptor tyrosine-protein kinase erbB-1; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; ERBB; HER1; mENA; PIG61;
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.